Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies

[1] Fauci AS(2020)COVID-19—navigating the Uncharted N Engl J Med 382 1268-1269

[2] Lane HC(2020)An Italian programme for COVID-19 infection in multiple sclerosis Lancet Neurol 19 481-482

[3] Redfield RR(2021)Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register J Neurol Neurosurg Psychiatry 92 107-109

[4] Sormani MP(2020)Multiple sclerosis and COVID-19: how many are at risk? Eur J Neurol 8 e1001-e130

[5] Evangelou N(2021)COVID-19 among patients with multiple sclerosis: a systematic review Neurol Neuroimmunol Neuroinflamm 3 e123-192

[6] Garjani A(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Open Med 192 1057-644

[7] dasNair R, G(2013)Using PICO to align medical evidence with MDs decision making models Stud Health Technol Inform 81 184-1260

[8] Bsteh C(2013)Mortality in patients with multiple sclerosis Neurology 23 643-1088

[9] Bitschnau H(1994)Age-standardization in epidemiological data Int J Epidemiol 51 102886-708

[10] Hegen M(2021)COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America Mult Scler Relat Disord 52 103004-789

[1] Fauci AS(2020)COVID-19—navigating the Uncharted N Engl J Med 382 1268-1269

[2] Lane HC(2020)An Italian programme for COVID-19 infection in multiple sclerosis Lancet Neurol 19 481-482

[3] Redfield RR(2021)Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register J Neurol Neurosurg Psychiatry 92 107-109

[4] Sormani MP(2020)Multiple sclerosis and COVID-19: how many are at risk? Eur J Neurol 8 e1001-e130

[5] Evangelou N(2021)COVID-19 among patients with multiple sclerosis: a systematic review Neurol Neuroimmunol Neuroinflamm 3 e123-192

[6] Garjani A(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Open Med 192 1057-644

[7] dasNair R, G(2013)Using PICO to align medical evidence with MDs decision making models Stud Health Technol Inform 81 184-1260

[8] Bsteh C(2013)Mortality in patients with multiple sclerosis Neurology 23 643-1088

[9] Bitschnau H(1994)Age-standardization in epidemiological data Int J Epidemiol 51 102886-708

[10] Hegen M(2021)COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America Mult Scler Relat Disord 52 103004-789